Clinical Trial Update: The Effects of Decreasing the Lasix Dose on the Cardiorenal System [Phase 1, Phase 2]

View source ↗

Summary

A Mayo Clinic clinical trial studied whether decreasing the dose of Lasix (furosemide) affects cardiorenal outcomes in patients with heart failure and kidney dy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Heart Failure

Drugs mentioned

• Lasix (furosemide)

Snippet

Sponsor: Mayo Clinic | Conditions: Heart Failure, Kidney Dysfunction | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2015-07-20